NASDAQ:ABIO ARCA biopharma (ABIO) Stock Forecast, Price & News $2.01 0.00 (0.00%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range$2.01▼$2.0250-Day Range$2.00▼$2.0752-Week Range$1.85▼$2.70Volume18,760 shsAverage Volume22,521 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About ARCA biopharma (NASDAQ:ABIO) StockARCA biopharma, Inc., a clinical development stage biopharmaceutical company, engages in the development and commercialization of genetically targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. It is also developing Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. The company was founded in 2004 and is headquartered in Westminster, Colorado.Read More ABIO Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ABIO Stock News HeadlinesSeptember 27, 2023 | msn.comARCA legend Kimmel keeps the racing itch scratched as a truck chief with TRICONSeptember 25, 2023 | americanbankingnews.comARCA biopharma (NASDAQ:ABIO) Receives New Coverage from Analysts at StockNews.comOctober 1, 2023 | Behind the Markets (Ad)3 Words and a 3,000% ReturnIn October 2013, a scientist wrote 3 words on a piece of paper. They were simple words. A fiveyear-old could say them. But these three words could deliver you a 3,000% return in 2023 >>>September 21, 2023 | msn.comARCA Wunderkind: NASCAR Fans Should 'Love' Who's Coming Down the RoadSeptember 10, 2023 | uk.finance.yahoo.comABIO - ARCA biopharma, Inc.September 8, 2023 | msn.comRookie Connor Mosack wins first career ARCA race at Kansas SpeedwaySeptember 6, 2023 | msn.comFive drivers to watch in Friday’s ARCA Sioux Chief Fast Track 150 at Kansas SpeedwayAugust 22, 2023 | msn.comRacing for Stride ARCA driver honors disabled veteransOctober 1, 2023 | Behind the Markets (Ad)3 Words and a 3,000% ReturnIn October 2013, a scientist wrote 3 words on a piece of paper. They were simple words. A fiveyear-old could say them. But these three words could deliver you a 3,000% return in 2023 >>>August 18, 2023 | msn.comWatkins Glen Day 1 Recap: ARCA race comes down to final turn; tough day for Frankie MunizAugust 18, 2023 | msn.comLove bumps Zilisch on last lap to win ARCA race at Watkins GlenAugust 18, 2023 | msn.comFrankie Muniz sees Watkins Glen as chance to earn first career ARCA victoryAugust 14, 2023 | msn.comCorey LaJoie enters ARCA Menards Series race for Watkins Glen weekendAugust 13, 2023 | msn.comARCA drivers Christian Rose, Conner Jones get into heated scuffle after spin outAugust 11, 2023 | yahoo.comActor Turned Racer Frankie Muniz Is No Joke in ARCA Racing SeriesJuly 30, 2023 | finanznachrichten.deARCA biopharma, Inc.: ARCA biopharma Announces Second Quarter 2023 Financial ResultsJuly 27, 2023 | sports.yahoo.comSekisui Voltek Announces Sponsorship of Coldwater's Rodgers for ARCA raceJuly 21, 2023 | sports.yahoo.comPOCONOTES: Actor Muniz in middle of ARCA points battleJuly 21, 2023 | finance.yahoo.comARCA biopharma Announces Second Quarter 2023 Financial ResultsJuly 15, 2023 | msn.comFenhaus wins Calypso 150 in ARCA Menards SeriesJuly 15, 2023 | sports.yahoo.com'The end goal is the Cup Series': Frankie Muniz seeking more in NASCAR than hot ARCA startJuly 13, 2023 | finance.yahoo.comWe're Not Very Worried About ARCA biopharma's (NASDAQ:ABIO) Cash Burn RateJuly 11, 2023 | msn.comARCA driver Sean Hingorani suspended for wrecking teammateJuly 10, 2023 | yahoo.comARCA-Level NASCAR Driver Suspended for Wrecking TeammateJune 25, 2023 | msn.comFrankie Muniz crashes hard in ARCA race, picks up first DNFJune 15, 2023 | msn.comFrankie Muniz, Jesse Love and Christian Rose highlight who to watch for in the Berlin ARCA 200 this SaturdayMay 4, 2023 | msn.comConnor Mosack: "We’ve done everything in ARCA but win"See More Headlines Receive ABIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address ABIO Company Calendar Last Earnings7/21/2023Today10/01/2023Next Earnings (Estimated)10/27/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Diagnostic substances Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:ABIO CUSIPN/A CIK907654 Webarcabio.com Phone(720) 940-2100Fax720-208-9261Employees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.43) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,930,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-15.43% Return on Assets-14.80% Debt Debt-to-Equity RatioN/A Current Ratio25.44 Quick Ratio25.44 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$2.89 per share Price / Book0.70Miscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta1.30 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesDr. Michael R. Bristow M.D. (Age 78)Ph.D., Co-Founder, Pres, CEO & Director Comp: $358.8kMr. Thomas A. Keuer (Age 64)Chief Operating Officer Comp: $360.59kMr. C. Jeffrey Dekker CPA (Age 58)Chief Financial Officer Key Competitors60 Degrees Pharmaceuticals, Inc. WarrantNASDAQ:SXTPWAclarionNASDAQ:ACONWAinosNASDAQ:AIMDWAlpha Tau MedicalNASDAQ:DRTSWAlvotechNASDAQ:ALVOWView All CompetitorsInstitutional OwnershipWestern Standard LLCBought 630,191 shares on 8/15/2023Ownership: 0.000%BlackRock Inc.Sold 32,772 shares on 8/11/2023Ownership: 0.000%View All Institutional Transactions ABIO Stock - Frequently Asked Questions How have ABIO shares performed in 2023? ARCA biopharma's stock was trading at $2.37 at the beginning of 2023. Since then, ABIO stock has decreased by 15.2% and is now trading at $2.01. View the best growth stocks for 2023 here. Are investors shorting ARCA biopharma? ARCA biopharma saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 265,000 shares, an increase of 9.5% from the August 31st total of 242,000 shares. Based on an average daily trading volume, of 20,600 shares, the short-interest ratio is currently 12.9 days. Currently, 1.9% of the company's stock are sold short. View ARCA biopharma's Short Interest. When is ARCA biopharma's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, October 27th 2023. View our ABIO earnings forecast. How were ARCA biopharma's earnings last quarter? ARCA biopharma, Inc. (NASDAQ:ABIO) released its quarterly earnings data on Friday, July, 21st. The biopharmaceutical company reported ($0.10) earnings per share (EPS) for the quarter. What is Michael R. Bristow's approval rating as ARCA biopharma's CEO? 1 employees have rated ARCA biopharma Chief Executive Officer Michael R. Bristow on Glassdoor.com. Michael R. Bristow has an approval rating of 100% among the company's employees. This puts Michael R. Bristow in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of ARCA biopharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other ARCA biopharma investors own include Aurora Cannabis (ACBFF), MannKind (MNKD), Bausch Health Companies (BHC), Biocept (BIOC), Novavax (NVAX), AVEO Pharmaceuticals (AVEO), Gilead Sciences (GILD), iBio (IBIO), Nabriva Therapeutics (NBRV) and Synergy Pharmaceuticals (SGYP). What is ARCA biopharma's stock symbol? ARCA biopharma trades on the NASDAQ under the ticker symbol "ABIO." How do I buy shares of ARCA biopharma? Shares of ABIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is ARCA biopharma's stock price today? One share of ABIO stock can currently be purchased for approximately $2.01. How can I contact ARCA biopharma? ARCA biopharma's mailing address is 11080 CIRCLEPOINT ROAD SUITE 140, WESTMINSTER CO, 80020. The official website for the company is arcabio.com. The biopharmaceutical company can be reached via phone at (720) 940-2100, via email at derek.cole@arcabio.com, or via fax at 720-208-9261. This page (NASDAQ:ABIO) was last updated on 10/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARCA biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.